clinical trial · NCT06854042
A Study of Oral E1018 in Healthy Adult Participants
MalariaHealthy ParticipantsE1018Placebo
brief summary
The primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.
started
Feb 26, 2025
primary completion
Jul 22, 2027
completion
Jul 22, 2027
last updated
Aug 7, 2026
official title
A First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral E1018 in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol